Koers Nemus Bioscience Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 365 mln. 339 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,34 mln. | Nettowinst (verlies) 2025 * | -34 mln. -31,55 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-16,6
x | K/w-verhouding 2025 * |
-14,9
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,92% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19-01-18 |
Director of Finance/CFO | - | 05-10-21 | |
Chief Tech/Sci/R&D Officer | 52 | 13-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 07-08-20 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 22-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 18-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,84% | 47,9 mld. | |
+46,56% | 41,42 mld. | |
-2,31% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+10,74% | 25,55 mld. | |
-21,68% | 19,27 mld. | |
-2,14% | 12,15 mld. | |
+31,05% | 12,14 mld. | |
-0,67% | 11,99 mld. |